BioPlus Acquisition Corp. (BIOS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.11B |
| Enterprise Value | 6.11B |
| P/E Ratio | 1,255.23 |
| PEG Ratio | 0.08 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 28.94 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -182.69 |
Fiscal Year
| Fiscal Year | December 31, 2022 |
| Most Recent Quarter | June 30, 2023 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.02 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1.17M |
| EBITDA | -1.17M |
| Net Income | 5.16M |
| Diluted EPS | 0.2 |
Balance Sheet
| Total Cash | 2,454 |
| Total Cash/Share | 0 |
| Total Debt | 5.25M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 1.04 |
| Book Value Per Share | 0.37 |
Price History
| 52-Week Change | 6.56 |
| 52-Week High | 11.68 |
| 52-Week Low | 10.12 |
| Moving Average 50 Days | 10.77 |
| Moving Average 200 Days | 10.55 |
Statistics
| Average Volume | 35,934 |
| Shares Outstanding | 19.37M |
| % Held by Institutions | 0.01 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
